Simona Landonio

Milan, Italy

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 22 publications

A real-world implementation study of a TDM-guided dalbavancin model for bone and joint infections (101 Dalbatians).

A real-world implementation study of a TDM-guided dalbavancin model for bone and joint infections (101 Dalbatians).

Journal: JAC-antimicrobial resistance

Published: June 08, 2026

High Symptom Burden in Patients With Advanced Chronic or Prolonged Infectious Diseases: Not Only Pain.

High Symptom Burden in Patients With Advanced Chronic or Prolonged Infectious Diseases: Not Only Pain.

Journal: Cureus

Published: October 17, 2024

Traditional Cultures versus Next Generation Sequencing for Suspected Orthopedic Infection: Experience Gained from a Reference Centre.

Traditional Cultures versus Next Generation Sequencing for Suspected Orthopedic Infection: Experience Gained from a Reference Centre.

Journal: Antibiotics (Basel, Switzerland)

Published: October 15, 2023

Comparison of three therapeutic regimens for genotype-3 hepatitis C virus infection in a large real-life multicentre cohort.

Comparison of three therapeutic regimens for genotype-3 hepatitis C virus infection in a large real-life multicentre cohort.

Journal: Liver international : official journal of the International Association for the Study of the Liver

Published: September 20, 2019

Real-life effectiveness and safety of sofosbuvir/velpatasvir/voxilaprevir in hepatitis C patients with previous DAA failure.

Real-life effectiveness and safety of sofosbuvir/velpatasvir/voxilaprevir in hepatitis C patients with previous DAA failure.

Journal: Journal of hepatology

Published: February 28, 2019

Are direct-acting antivirals safe and effective in hepatitis C virus-cryoglobulinemia? virological, immunological, and clinical data from a real-life experience.

Are direct-acting antivirals safe and effective in hepatitis C virus-cryoglobulinemia? virological, immunological, and clinical data from a real-life experience.

Journal: European journal of gastroenterology & hepatology

Published: August 24, 2018

Real-world effectiveness and safety of glecaprevir/pibrentasvir in 723 patients with chronic hepatitis C.

Real-world effectiveness and safety of glecaprevir/pibrentasvir in 723 patients with chronic hepatitis C.

Journal: Journal of hepatology

Published: August 08, 2018

Strategic use of dual regimens of boosted protease inhibitors plus maraviroc in poorly adherent subjects in view of long-acting drugs: A retrospective study.

Strategic use of dual regimens of boosted protease inhibitors plus maraviroc in poorly adherent subjects in view of long-acting drugs: A retrospective study.

Journal: Medicine

Published: February 17, 2017

Multiclass HCV resistance to direct-acting antiviral failure in real-life patients advocates for tailored second-line therapies.

Multiclass HCV resistance to direct-acting antiviral failure in real-life patients advocates for tailored second-line therapies.

Journal: Liver international : official journal of the International Association for the Study of the Liver

Published: September 30, 2016

Breast Hypertrophy Induced by Ombitasvir/Paritaprevir/Ritonavir and Ribavirina.

Breast Hypertrophy Induced by Ombitasvir/Paritaprevir/Ritonavir and Ribavirina.

Journal: The breast journal

Published: August 05, 2016

HCV NS3 sequencing as a reliable and clinically useful tool for the assessment of genotype and resistance mutations for clinical samples with different HCV-RNA levels.

HCV NS3 sequencing as a reliable and clinically useful tool for the assessment of genotype and resistance mutations for clinical samples with different HCV-RNA levels.

Journal: The Journal of antimicrobial chemotherapy

Published: July 29, 2015

ITPA and SLC29A1 Genotyping for the Prediction of Ribavirin Dose Reduction in Anti-HCV Triple Therapy with Protease Inhibitors.

ITPA and SLC29A1 Genotyping for the Prediction of Ribavirin Dose Reduction in Anti-HCV Triple Therapy with Protease Inhibitors.

Journal: Pharmacology

Published: June 22, 2015

Showing 1-12 of 22

Last Updated: 09/26/2026